pentosidine has been researched along with Osteoporosis in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.35) | 18.2507 |
| 2000's | 7 (30.43) | 29.6817 |
| 2010's | 14 (60.87) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Kida, Y; Marumo, K; Saito, M; Shinohara, A; Soshi, S | 1 |
| Ikegami, S; Kato, H; Nakamura, Y; Nakano, M; Sakai, N; Suzuki, T; Takahashi, J; Tokida, R; Uehara, M | 1 |
| Banno, T; Fujita, T; Matsuyama, Y; Nishida, T; Ohishi, T; Okabayashi, R; Suzuki, D; Ushirozako, H; Yamamoto, K | 1 |
| Ito, K; Koike, H; Matsui, H; Miyazawa, Y; Nomura, M; Sekine, Y; Shibata, Y; Suzuki, K; Syuto, T | 1 |
| Marumo, K; Saito, M | 2 |
| Yamauchi, M | 1 |
| Miyakoshi, N | 1 |
| Amling, M; Busse, B; Campbell, GM; Püschel, K; Schmidt, FN; Sroga, GE; Tang, SY; Vashishth, D; Zimmermann, EA | 1 |
| Kida, Y; Marumo, K; Saito, M; Shinohara, A; Soshi, S; Ushiku, C | 1 |
| Saito, M | 3 |
| Higuchi, T; Kuroda, T; Saito, M; Shiraki, M; Shiraki, Y; Tanaka, S | 1 |
| Kato, S; Kida, Y; Kuroda, T; Marumo, K; Saito, M; Takao-Kawabata, R; Ushiku, C | 1 |
| Hosoya, T; Marumo, K; Mitome, J; Saito, M; Yamamoto, H; Yokoyama, K | 1 |
| Suzuki, A | 1 |
| Yamamoto, M | 1 |
| Franke, S; Hein, G; Lehmann, G; Stein, G; Wiegand, R | 1 |
| Agrawal, CM; Li, X; Shen, X; Wang, X | 1 |
| Cirnigliaro, M; Federici, A; Federici, M; Monacelli, F; Odetti, P; Poggi, A; Rossi, S | 1 |
| Arlot, ME; Bouxsein, ML; Byrjalsen, I; Delmas, PD; Leeming, DJ; Merabet, Z; Roux, JP; Viguet-Carrin, S | 1 |
| Hoshino, H; Inoue, T; Kawana, K; Kushida, K; Ohishi, T; Takahashi, M; Uchiyama, A | 1 |
9 review(s) available for pentosidine and Osteoporosis
| Article | Year |
|---|---|
[Determinants of bone quality and strength independent of bone remodeling].
Topics: Aging; Animals; Arginine; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Collagen; Diphosphonates; Female; Fractures, Stress; Glucocorticoids; Glycation End Products, Advanced; Humans; Lysine; Male; Osteoporosis; Precision Medicine; Selective Estrogen Receptor Modulators | 2016 |
[The assessment of bone quality in lifestyle-related diseases].
Topics: Arginine; Biomarkers; Bone and Bones; Bone Remodeling; Collagen; Diabetes Mellitus, Type 2; Homocysteine; Humans; Hyperhomocysteinemia; Life Style; Lysine; Osteoporosis; Pulmonary Disease, Chronic Obstructive; Renal Insufficiency, Chronic; Risk; Tomography, X-Ray Computed | 2016 |
[Changes in bone quality and strength with bone-forming agents].
Topics: Anabolic Agents; Animals; Arginine; Bone and Bones; Bone Density; Collagen; Compressive Strength; Female; Fractures, Stress; Glycation End Products, Advanced; Haplorhini; Humans; Lysine; Osteogenesis; Osteoporosis; Rats; Spinal Fractures; Teriparatide | 2016 |
[Biochemical markers of bone turnover. New aspect. Bone collagen metabolism: new biological markers for estimation of bone quality].
Topics: Arginine; Biomarkers; Bone and Bones; Bone Density; Bone Remodeling; Bone Resorption; Collagen; Glycation End Products, Advanced; Homocysteine; Humans; Lysine; Osteoporosis; Oxidative Stress | 2009 |
[Poor bone quality in diabetes and arterioscelerosis].
Topics: Animals; Arginine; Arteriosclerosis; Biomarkers; Bone Density; Collagen; Diabetes Complications; Diabetes Mellitus; Fractures, Bone; Glycation End Products, Advanced; Homocysteine; Humans; Lysine; Osteoporosis; Risk | 2009 |
[Bone quality markers: pentosidine, homocysteine, and MTHFR polymorphism].
Topics: Arginine; Biomarkers; Female; Homocysteine; Humans; Lysine; Methylenetetrahydrofolate Reductase (NADPH2); Osteoporosis; Polymorphism, Genetic | 2009 |
[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Bone quality in chronic kidney disease : enzymatic and non-enzymatic glycation or oxidation induced cross-links in bone].
Topics: Animals; Arginine; Bone and Bones; Bone Diseases, Metabolic; Chronic Disease; Collagen; Fractures, Bone; Glycation End Products, Advanced; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Diseases; Lysine; Osteoporosis; Oxidative Stress; Risk | 2010 |
[Is bone biopsy necessary for the diagnosis of metabolic bone diseases? Non- invasive assessment of bone turn over markers could define the cause of metabolic bone diseases].
Topics: Acid Phosphatase; Alkaline Phosphatase; Arginine; Biomarkers; Biopsy; Bone and Bones; Bone Diseases, Metabolic; Collagen Type I; Diagnosis, Differential; Homocysteine; Humans; Isoenzymes; Lysine; Osteoporosis; Peptide Fragments; Peptides; Procollagen; Tartrate-Resistant Acid Phosphatase | 2011 |
[Diabetes mellitus and osteoporosis. Predictive candidate markers for fracture risk in diabetic patients].
Topics: Arginine; Diabetes Mellitus, Type 2; Fractures, Bone; Humans; Lysine; Osteoporosis; Risk Factors | 2012 |
14 other study(ies) available for pentosidine and Osteoporosis
| Article | Year |
|---|---|
Non-invasive skin autofluorescence, blood and urine assays of the advanced glycation end product (AGE) pentosidine as an indirect indicator of AGE content in human bone.
Topics: Adult; Aged; Arginine; Bone and Bones; Bone Density; Collagen; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Optical Imaging; Osteoporosis; Osteoporotic Fractures; Oxidative Stress; Sex Factors; Skin | 2019 |
Reference values for bone metabolism in a Japanese cohort survey randomly sampled from a basic elderly resident registry.
Topics: Aged; Aged, 80 and over; Aging; Alkaline Phosphatase; Arginine; Biomarkers; Bone Density; Bone Resorption; Cohort Studies; Female; Femur Neck; Hip; Humans; Japan; Lysine; Male; Middle Aged; Osteoporosis; Reference Values; Registries; Tartrate-Resistant Acid Phosphatase; Vitamin D | 2021 |
Changes of bone mineral density and serum pentosidine during a 27-month follow-up of monthly minodronate in osteoporotic patients.
Topics: Aged; Aged, 80 and over; Arginine; Bone Density; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Lysine; Middle Aged; Osteoporosis; Outcome Assessment, Health Care | 2017 |
Evaluation of Bone Turnover / Quality Markers and Bone Mineral Density in Prostate Cancer Patients Receiving Androgen Deprivation Therapy with or without Denosumab.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Arginine; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Denosumab; Femur Neck; Fractures, Bone; Humans; Lumbar Vertebrae; Lysine; Male; Middle Aged; Osteoporosis; Prostatic Neoplasms; Retrospective Studies; Tartrate-Resistant Acid Phosphatase | 2017 |
Assessment of collagen quality associated with non-enzymatic cross-links in human bone using Fourier-transform infrared imaging.
Topics: Adolescent; Arginine; Bone and Bones; Collagen; Cross-Linking Reagents; Diphosphonates; Humans; Lysine; Middle Aged; Osteoporosis; Ribose; Spectroscopy, Fourier Transform Infrared | 2017 |
Raloxifene ameliorates detrimental enzymatic and nonenzymatic collagen cross-links and bone strength in rabbits with hyperhomocysteinemia.
Topics: Animals; Arginine; Bone and Bones; Bone Density; Bone Density Conservation Agents; Collagen; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Glycation End Products, Advanced; Hyperhomocysteinemia; Lysine; Methionine; Osteoporosis; Rabbits; Raloxifene Hydrochloride; Stress, Mechanical | 2010 |
Urinary pentosidine and plasma homocysteine levels at baseline predict future fractures in osteoporosis patients under bisphosphonate treatment.
Topics: Aged; Arginine; Bone Density; Bone Density Conservation Agents; Diphosphonates; Female; Fractures, Bone; Homocysteine; Humans; Lysine; Middle Aged; Osteoporosis; Proportional Hazards Models | 2011 |
Changes in the contents of enzymatic immature, mature, and non-enzymatic senescent cross-links of collagen after once-weekly treatment with human parathyroid hormone (1-34) for 18 months contribute to improvement of bone strength in ovariectomized monkeys
Topics: Animals; Arginine; Bone Density; Bone Density Conservation Agents; Calcium; Collagen; Compressive Strength; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Female; Glycation End Products, Advanced; Lumbar Vertebrae; Lysine; Macaca fascicularis; Osteoporosis; Ovariectomy; Phosphates; Teriparatide; X-Ray Microtomography | 2011 |
Nonenzymatic cross-linking pentosidine increase in bone collagen and are associated with disorders of bone mineralization in dialysis patients.
Topics: Adult; Aged; Arginine; Bone and Bones; Bone Diseases; Calcification, Physiologic; Case-Control Studies; Collagen; Cross-Linking Reagents; Female; Glycation End Products, Advanced; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lysine; Male; Middle Aged; Osteoporosis; Renal Dialysis; Up-Regulation | 2011 |
Advanced glycation end-products pentosidine and N epsilon-carboxymethyllysine are elevated in serum of patients with osteoporosis.
Topics: Adult; Aged; Analysis of Variance; Arginine; Bone Resorption; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Osteoporosis | 2003 |
Age-related changes of noncalcified collagen in human cortical bone.
Topics: Adult; Aged; Aging; Arginine; Bone Remodeling; Cadaver; Collagen; Cross-Linking Reagents; Elasticity; Female; Femoral Fractures; Femur; Haversian System; Humans; Lysine; Male; Middle Aged; Osteogenesis; Osteoporosis; Protein Denaturation | 2003 |
Advanced glycation end products and bone loss during aging.
Topics: Aged; Aged, 80 and over; Arginine; Bone and Bones; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Osteoporosis | 2005 |
Contribution of the advanced glycation end product pentosidine and of maturation of type I collagen to compressive biomechanical properties of human lumbar vertebrae.
Topics: Absorptiometry, Photon; Adult; Aged; Aged, 80 and over; Arginine; Biomechanical Phenomena; Bone Density; Cadaver; Collagen Type I; Female; Glycation End Products, Advanced; Humans; Lumbar Vertebrae; Lysine; Male; Middle Aged; Osteoporosis | 2006 |
Quantitative analysis of crosslinks pyridinoline and pentosidine in articular cartilage of patients with bone and joint disorders.
Topics: Adult; Aged; Aged, 80 and over; Aging; Amino Acids; Arginine; Arthritis, Rheumatoid; Bone Diseases; Cartilage, Articular; Chromatography, High Pressure Liquid; Chronic Kidney Disease-Mineral and Bone Disorder; Cross-Linking Reagents; Female; Femur Head Necrosis; Hip Joint; Humans; Joint Diseases; Knee Joint; Lysine; Male; Middle Aged; Osteoarthritis; Osteoporosis | 1994 |